GTPBP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.926800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.389000E-01
Normal-vs-Stage2
6.708000E-01
Normal-vs-Stage3
4.572400E-01
Normal-vs-Stage4
5.471200E-01
Stage1-vs-Stage2
7.742800E-01
Stage1-vs-Stage3
4.903000E-01
Stage1-vs-Stage4
8.855200E-01
Stage2-vs-Stage3
2.771000E-01
Stage2-vs-Stage4
7.404000E-01
Stage3-vs-Stage4
6.040000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.301200E-01
Normal-vs-AfricanAmerican
9.468400E-01
Normal-vs-Asian
8.901000E-01
Caucasian-vs-AfricanAmerican
4.435000E-01
Caucasian-vs-Asian
2.908800E-01
AfricanAmerican-vs-Asian
7.871600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.643600E-01
Normal-vs-Female
5.020200E-01
Male-vs-Female
5.794600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.113200E-01
Normal-vs-Age(41-60Yrs)
8.663400E-01
Normal-vs-Age(61-80Yrs)
5.400200E-01
Normal-vs-Age(81-100Yrs)
2.306800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.852200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.898400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.741200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.805900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.985500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.163200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.740600E-01
Normal-vs-Daily Drinker
3.917000E-01
Normal-vs-Weekly Drinker
6.548600E-01
Normal-vs-Occasional Drinker
8.601800E-01
Normal-vs-Social Drinker
4.305400E-01
Non Drinker-vs-Daily Drinker
4.924800E-01
Non Drinker-vs-Weekly Drinker
9.432800E-01
Non Drinker-vs-Occasional Drinker
5.292000E-01
Non Drinker-vs-Social Drinker
8.870200E-01
Daily Drinker-vs-Weekly Drinker
4.599200E-01
Daily Drinker-vs-Occasional Drinker
1.558350E-01
Daily Drinker-vs-Social Drinker
4.822400E-01
Weekly Drinker-vs-Occasional Drinker
5.771400E-01
Weekly Drinker-vs-Social Drinker
8.228800E-01
Occasional Drinker-vs-Social Drinker
3.572200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.094800E-01
Normal-vs-Grade 2
4.374200E-02
Normal-vs-Grade 3
5.163800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.064450E-01
Grade 1-vs-Grade 3
4.220400E-01
Grade 1-vs-Grade 4
2.094800E-01
Grade 2-vs-Grade 3
2.504000E-01
Grade 2-vs-Grade 4
4.374200E-02
Grade 3-vs-Grade 4
5.163800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.390800E-01
Normal-vs-NonDiabetic
6.368600E-01
Diabetic-vs-NonDiabetic
4.762000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.169600E-01
Normal-vs-NoPancreatitis
5.494200E-01
Pancreatitis-vs-NoPancreatitis
9.694400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.194400E-01
Normal-vs-N1
6.344400E-01
N0-vs-N1
6.186200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.873600E-01
Normal-vs-TP53-NonMutant
6.750000E-01
TP53-Mutant-vs-TP53-NonMutant
4.394500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
